-
1
-
-
78049485263
-
Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008
-
Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM,. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer. 2010; 127: 2893-2917.
-
(2010)
Int J Cancer.
, vol.127
, pp. 2893-2917
-
-
Ferlay, J.1
Shin, H.R.2
Bray, F.3
Forman, D.4
Mathers, C.5
Parkin, D.M.6
-
2
-
-
0028936320
-
Adenocarcinoma of the esophagus: Role of obesity and diet
-
Brown LM, Swanson CA, Gridley G, et al. Adenocarcinoma of the esophagus: role of obesity and diet. J Natl Cancer Inst. 1995; 87: 104-109.
-
(1995)
J Natl Cancer Inst.
, vol.87
, pp. 104-109
-
-
Brown, L.M.1
Swanson, C.A.2
Gridley, G.3
-
3
-
-
51049091878
-
Incidence of adenocarcinoma of the esophagus among white Americans by sex, stage, and age
-
Brown LM, Devesa SS, Chow WH,. Incidence of adenocarcinoma of the esophagus among white Americans by sex, stage, and age. J Natl Cancer Inst. 2008; 100: 1184-1187.
-
(2008)
J Natl Cancer Inst.
, vol.100
, pp. 1184-1187
-
-
Brown, L.M.1
Devesa, S.S.2
Chow, W.H.3
-
4
-
-
13744258445
-
The role of overdiagnosis and reclassification in the marked increase of esophageal adenocarcinoma incidence
-
Pohl H, Welch HG,. The role of overdiagnosis and reclassification in the marked increase of esophageal adenocarcinoma incidence. J Natl Cancer Inst. 2005; 97: 142-146.
-
(2005)
J Natl Cancer Inst.
, vol.97
, pp. 142-146
-
-
Pohl, H.1
Welch, H.G.2
-
5
-
-
34548516386
-
Long-term results of RTOG trial 8911 (USA Intergroup 113): A random assignment trial comparison of chemotherapy followed by surgery compared with surgery alone for esophageal cancer
-
Kelsen DP, Winter KA, Gunderson LL, et al. Long-term results of RTOG trial 8911 (USA Intergroup 113): a random assignment trial comparison of chemotherapy followed by surgery compared with surgery alone for esophageal cancer. J Clin Oncol. 2007; 25: 3719-3725.
-
(2007)
J Clin Oncol.
, vol.25
, pp. 3719-3725
-
-
Kelsen, D.P.1
Winter, K.A.2
Gunderson, L.L.3
-
6
-
-
0030793423
-
Chemoradiotherapy followed by surgery compared with surgery alone in squamous-cell cancer of the esophagus
-
Bosset JF, Gignoux M, Triboulet JP, et al. Chemoradiotherapy followed by surgery compared with surgery alone in squamous-cell cancer of the esophagus. N Engl J Med. 1997; 337: 161-167.
-
(1997)
N Engl J Med.
, vol.337
, pp. 161-167
-
-
Bosset, J.F.1
Gignoux, M.2
Triboulet, J.P.3
-
7
-
-
0029737381
-
A comparison of multimodal therapy and surgery for esophageal adenocarcinoma
-
Walsh TN, Noonan N, Hollywood D, Kelly A, Keeling N, Hennessy TP,. A comparison of multimodal therapy and surgery for esophageal adenocarcinoma. N Engl J Med. 1996; 335: 462-467.
-
(1996)
N Engl J Med.
, vol.335
, pp. 462-467
-
-
Walsh, T.N.1
Noonan, N.2
Hollywood, D.3
Kelly, A.4
Keeling, N.5
Hennessy, T.P.6
-
8
-
-
34748850732
-
Chemoradiation in the management of esophageal cancer
-
Kleinberg L, Forastiere AA,. Chemoradiation in the management of esophageal cancer. J Clin Oncol. 2007; 25: 4110-4117.
-
(2007)
J Clin Oncol.
, vol.25
, pp. 4110-4117
-
-
Kleinberg, L.1
Forastiere, A.A.2
-
9
-
-
41949119177
-
Phase III trial of trimodality therapy with cisplatin, fluorouracil, radiotherapy, and surgery compared with surgery alone for esophageal cancer: CALGB 9781
-
Tepper J, Krasna MJ, Niedzwiecki D, et al. Phase III trial of trimodality therapy with cisplatin, fluorouracil, radiotherapy, and surgery compared with surgery alone for esophageal cancer: CALGB 9781. J Clin Oncol. 2008; 26: 1086-1092.
-
(2008)
J Clin Oncol.
, vol.26
, pp. 1086-1092
-
-
Tepper, J.1
Krasna, M.J.2
Niedzwiecki, D.3
-
10
-
-
78650167757
-
Effect of preoperative concurrent chemoradiotherapy on survival of patients with resectable esophageal or esophagogastric junction cancer: Results from a multicenter randomized phase III study [abstract 4004]
-
Gaast A, van Hagen P, Hulshof M, et al. Effect of preoperative concurrent chemoradiotherapy on survival of patients with resectable esophageal or esophagogastric junction cancer: results from a multicenter randomized phase III study [abstract 4004]. J Clin Oncol. 2010; 28 (suppl): 15s.
-
(2010)
J Clin Oncol.
, vol.28
, Issue.SUPPL.
-
-
Gaast, A.1
Van Hagen, P.2
Hulshof, M.3
-
11
-
-
0026671413
-
Treatment of locoregional esophageal cancer
-
Forastiere AA,. Treatment of locoregional esophageal cancer. Semin Oncol. 1992; 19 (4 suppl 11): 57-63.
-
(1992)
Semin Oncol.
, vol.19
, Issue.4 SUPPL. 11
, pp. 57-63
-
-
Forastiere, A.A.1
-
12
-
-
0033212165
-
Principles of chemoradiation: Theoretical and practical considerations
-
Herscher LL, Cook JA, Pacelli R, Pass HI, Russo A, Mitchell JB,. Principles of chemoradiation: theoretical and practical considerations. Oncology (Williston Park). 1999; 13 (10 suppl 5): 11-22.
-
(1999)
Oncology (Williston Park).
, vol.13
, Issue.10 SUPPL. 5
, pp. 11-22
-
-
Herscher, L.L.1
Cook, J.A.2
Pacelli, R.3
Pass, H.I.4
Russo, A.5
Mitchell, J.B.6
-
14
-
-
0036499029
-
INT 0123 (Radiation Therapy Oncology Group 94-05) phase III trial of combined-modality therapy for esophageal cancer: High-dose versus standard-dose radiation therapy
-
Minsky BD, Pajak TF, Ginsberg RJ, et al. INT 0123 (Radiation Therapy Oncology Group 94-05) phase III trial of combined-modality therapy for esophageal cancer: high-dose versus standard-dose radiation therapy. J Clin Oncol. 2002; 20: 1167-1174.
-
(2002)
J Clin Oncol.
, vol.20
, pp. 1167-1174
-
-
Minsky, B.D.1
Pajak, T.F.2
Ginsberg, R.J.3
-
15
-
-
34547838162
-
Challenges in the clinical application of advanced technologies to reduce radiation-associated normal tissue injury
-
Marks LB, Ma J,. Challenges in the clinical application of advanced technologies to reduce radiation-associated normal tissue injury. Int J Radiat Oncol Biol Phys. 2007; 69: 4-12.
-
(2007)
Int J Radiat Oncol Biol Phys.
, vol.69
, pp. 4-12
-
-
Marks, L.B.1
Ma, J.2
-
16
-
-
73749085802
-
Radiobiological basis and clinical results of the simultaneous integrated boost (SIB) in intensity modulated radiotherapy (IMRT) for head and neck cancer: A review
-
Orlandi E, Palazzi M, Pignoli E, Fallai C, Giostra A, Olmi P,. Radiobiological basis and clinical results of the simultaneous integrated boost (SIB) in intensity modulated radiotherapy (IMRT) for head and neck cancer: a review. Critical reviews in oncology/hematology 2010; 73: 111-125.
-
(2010)
Critical Reviews in Oncology/hematology
, vol.73
, pp. 111-125
-
-
Orlandi, E.1
Palazzi, M.2
Pignoli, E.3
Fallai, C.4
Giostra, A.5
Olmi, P.6
-
17
-
-
0036680314
-
Prostate cancer radiation dose response: Results of the M. D. Anderson phase III randomized trial
-
Pollack A, Zagars GK, Starkschall G, et al. Prostate cancer radiation dose response: results of the M. D. Anderson phase III randomized trial. Int J Radiat Oncol Biol Phys. 2002; 53: 1097-1105.
-
(2002)
Int J Radiat Oncol Biol Phys.
, vol.53
, pp. 1097-1105
-
-
Pollack, A.1
Zagars, G.K.2
Starkschall, G.3
-
18
-
-
0033045661
-
Estimation of tumor control probability model parameters from 3-D dose distributions of non-small cell lung cancer patients
-
Martel MK, Ten Haken RK, Hazuka MB, et al. Estimation of tumor control probability model parameters from 3-D dose distributions of non-small cell lung cancer patients. Lung Cancer. 1999; 24: 31-37.
-
(1999)
Lung Cancer.
, vol.24
, pp. 31-37
-
-
Martel, M.K.1
Ten Haken, R.K.2
Hazuka, M.B.3
-
19
-
-
24944432301
-
High-dose radiation improved local tumor control and overall survival in patients with inoperable/unresectable non-small-cell lung cancer: Long-term results of a radiation dose escalation study
-
Kong FM, Ten Haken RK, Schipper MJ, et al. High-dose radiation improved local tumor control and overall survival in patients with inoperable/ unresectable non-small-cell lung cancer: long-term results of a radiation dose escalation study. Int J Radiat Oncol Biol Phys. 2005; 63: 324-333.
-
(2005)
Int J Radiat Oncol Biol Phys.
, vol.63
, pp. 324-333
-
-
Kong, F.M.1
Ten Haken, R.K.2
Schipper, M.J.3
-
20
-
-
0036499029
-
INT 0123 (Radiation Therapy Oncology Group 94-05) phase III trial of combined-modality therapy for esophageal cancer: High-dose versus standard-dose radiation therapy
-
Minsky BD, Pajak TF, Ginsberg RJ,. INT 0123 (Radiation Therapy Oncology Group 94-05) phase III trial of combined-modality therapy for esophageal cancer: high-dose versus standard-dose radiation therapy. J Clin Oncol. 2002; 20: 1167-1174.
-
(2002)
J Clin Oncol.
, vol.20
, pp. 1167-1174
-
-
Minsky, B.D.1
Pajak, T.F.2
Ginsberg, R.J.3
-
21
-
-
77749246650
-
Intensity modulated proton therapy treatment planning using single-field optimization: The impact of monitor unit constraints on plan quality
-
Zhu XR, Sahoo N, Zhang X, et al. Intensity modulated proton therapy treatment planning using single-field optimization: the impact of monitor unit constraints on plan quality. Med Phys. 2010; 37: 1210-1219.
-
(2010)
Med Phys.
, vol.37
, pp. 1210-1219
-
-
Zhu, X.R.1
Sahoo, N.2
Zhang, X.3
-
22
-
-
83955161796
-
Esophageal cancer dose escalation using a simultaneous integrated boost technique [published online ahead of print November 29, 2010]
-
Welsh J, Palmer MB, Ajani JA, et al. Esophageal cancer dose escalation using a simultaneous integrated boost technique [published online ahead of print November 29, 2010]. Int J Radiat Oncol Biol Phys. doi: 10.1016/j.ijrobp.2010. 10.023.
-
Int J Radiat Oncol Biol Phys
-
-
Welsh, J.1
Palmer, M.B.2
Ajani, J.A.3
-
23
-
-
81855175302
-
Intensity modulated proton therapy allows dose escalation and normal-tissue sparing in locally advanced distal esophageal tumors [published online ahead of print April 4, 2011]
-
Welsh J, Riley B, Palmera M, et al. Intensity modulated proton therapy allows dose escalation and normal-tissue sparing in locally advanced distal esophageal tumors [published online ahead of print April 4, 2011]. Int J Radiat Oncol Biol Phys. doi: 10.1016/j.ijrobp.2010.07.2001.
-
Int J Radiat Oncol Biol Phys
-
-
Welsh, J.1
Riley, B.2
Palmera, M.3
-
24
-
-
0015631302
-
Time-dose and tumor volume relationships in the irradiation of squamous cell carcinoma of the tonsillar fossa
-
Shukovsky LJ, Fletcher GH,. Time-dose and tumor volume relationships in the irradiation of squamous cell carcinoma of the tonsillar fossa. Radiology. 1973; 107: 621-626.
-
(1973)
Radiology.
, vol.107
, pp. 621-626
-
-
Shukovsky, L.J.1
Fletcher, G.H.2
-
25
-
-
79960531830
-
Phase 2 study of high-dose proton therapy with concurrent chemotherapy for unresectable stage III nonsmall cell lung cancer [published online ahead of print March 22, 2011]
-
Chang JY, Komaki R, Lu C, et al. Phase 2 study of high-dose proton therapy with concurrent chemotherapy for unresectable stage III nonsmall cell lung cancer [published online ahead of print March 22, 2011]. Cancer. doi: 10.1002/cncr.26080.
-
Cancer
-
-
Chang, J.Y.1
Komaki, R.2
Lu, C.3
-
26
-
-
79960098577
-
Toxicity and patterns of failure of adaptive/ablative proton therapy for early-stage, medically inoperable non-small cell lung cancer
-
Chang JY, Komaki R, Wen HY, et al. Toxicity and patterns of failure of adaptive/ablative proton therapy for early-stage, medically inoperable non-small cell lung cancer. Int J Radiat Oncol Biol Phys. 2011; 80: 1350-1357.
-
(2011)
Int J Radiat Oncol Biol Phys.
, vol.80
, pp. 1350-1357
-
-
Chang, J.Y.1
Komaki, R.2
Wen, H.Y.3
-
27
-
-
78650829233
-
A treatment planning comparison between proton beam therapy and intensity-modulated x-ray therapy for recurrent nasopharyngeal carcinoma
-
Liu SW, Li JM, Chang JY, et al. A treatment planning comparison between proton beam therapy and intensity-modulated x-ray therapy for recurrent nasopharyngeal carcinoma. J Xray Sci Technol. 2010; 18: 443-450.
-
(2010)
J Xray Sci Technol.
, vol.18
, pp. 443-450
-
-
Liu, S.W.1
Li, J.M.2
Chang, J.Y.3
-
28
-
-
32144433159
-
Radiotherapy plus cetuximab for squamous-cell carcinoma of the head and neck
-
Bonner JA, Harari PM, Giralt J, et al. Radiotherapy plus cetuximab for squamous-cell carcinoma of the head and neck. N Engl J Med. 2006; 354: 567-578.
-
(2006)
N Engl J Med.
, vol.354
, pp. 567-578
-
-
Bonner, J.A.1
Harari, P.M.2
Giralt, J.3
-
29
-
-
70349937924
-
Phase II study of cetuximab in combination with cisplatin and docetaxel in patients with untreated advanced gastric or gastro-oesophageal junction adenocarcinoma (DOCETUX study)
-
Pinto C, Di Fabio F, Barone C, et al. Phase II study of cetuximab in combination with cisplatin and docetaxel in patients with untreated advanced gastric or gastro-oesophageal junction adenocarcinoma (DOCETUX study). Br J Cancer. 2009; 101: 1261-1268.
-
(2009)
Br J Cancer.
, vol.101
, pp. 1261-1268
-
-
Pinto, C.1
Di Fabio, F.2
Barone, C.3
-
30
-
-
79961123374
-
Cross-signaling among phosphinositide-3 kinase, mitogen-activated protein kinase and sonic hedgehog pathways exists in esophageal cancer
-
Wei L, Xu Z,. Cross-signaling among phosphinositide-3 kinase, mitogen-activated protein kinase and sonic hedgehog pathways exists in esophageal cancer. Int J Cancer. 2011; 129: 275-284.
-
(2011)
Int J Cancer.
, vol.129
, pp. 275-284
-
-
Wei, L.1
Xu, Z.2
-
31
-
-
68849084120
-
Novel targets in esophageal and gastric cancer: Beyond antiangiogenesis
-
Lee W, Patel JH, Lockhart AC,. Novel targets in esophageal and gastric cancer: beyond antiangiogenesis. Expert Opin Investig Drugs. 2009; 18: 1351-1364.
-
(2009)
Expert Opin Investig Drugs.
, vol.18
, pp. 1351-1364
-
-
Lee, W.1
Patel, J.H.2
Lockhart, A.C.3
-
32
-
-
0036680314
-
Prostate cancer radation dose response: Results of the M.D Anderson phase II randomized trial
-
Pollack A, Zagars GK, Starkschall G, et al. Prostate cancer radation dose response: results of the M.D Anderson phase II randomized trial. Int J Radiat Oncol Biol Phys. 2002; 53: 1097-1105.
-
(2002)
Int J Radiat Oncol Biol Phys.
, vol.53
, pp. 1097-1105
-
-
Pollack, A.1
Zagars, G.K.2
Starkschall, G.3
-
33
-
-
81855165636
-
116: Radiation-Induced Esophageal Stricture Following Therapy for Lung Cancer: Its Clinical Course and Analysis Comparing Stricture Length with Isodose Levels
-
Marks LB, Zeng J, Light K, Kahn D, Zhou S,. 116: Radiation-Induced Esophageal Stricture Following Therapy for Lung Cancer: Its Clinical Course and Analysis Comparing Stricture Length With Isodose Levels. Int J Radiat Oncol Biol Phys. 2006; 66 (3 suppl 1): S66-S67.
-
(2006)
Int J Radiat Oncol Biol Phys.
, vol.66
, Issue.3 SUPPL. 1
-
-
Marks, L.B.1
Zeng, J.2
Light, K.3
Kahn, D.4
Zhou, S.5
-
34
-
-
34548677048
-
A four-dimensional CT-based evaluation of techniques for gastric irradiation
-
van der Geld YG, Senan S, van Sornsen de Koste JR, Verbakel WFAR, Slotman BJ, Lagerwaard FJ,. A four-dimensional CT-based evaluation of techniques for gastric irradiation. Int J Radiat Oncol Biol Phys. 2007; 69: 903-909.
-
(2007)
Int J Radiat Oncol Biol Phys.
, vol.69
, pp. 903-909
-
-
Van Der Geld, Y.G.1
Senan, S.2
Van Sornsen De Koste, J.R.3
Verbakel, W.4
Slotman, B.J.5
Lagerwaard, F.J.6
-
35
-
-
0023493526
-
Radiotherapy of gastric cancer with a three field combination: Feasibility, tolerance, and survival
-
Caudry M, Escarmant P, Maire JP, Demeaux H, Guichard F, Azaloux H,. Radiotherapy of gastric cancer with a three field combination: feasibility, tolerance, and survival. Int J Radiat Oncol Biol Phys. 1987; 13: 1821-1827.
-
(1987)
Int J Radiat Oncol Biol Phys.
, vol.13
, pp. 1821-1827
-
-
Caudry, M.1
Escarmant, P.2
Maire, J.P.3
Demeaux, H.4
Guichard, F.5
Azaloux, H.6
-
36
-
-
79251546723
-
Induction chemotherapy with docetaxel/cisplatin/5-fluorouracil for patients with node-positive esophageal cancer
-
Watanabe M, Nagai Y, Kinoshita K, et al. Induction chemotherapy with docetaxel/cisplatin/5-fluorouracil for patients with node-positive esophageal cancer. Digestion. 2011; 83: 146-152.
-
(2011)
Digestion.
, vol.83
, pp. 146-152
-
-
Watanabe, M.1
Nagai, Y.2
Kinoshita, K.3
-
37
-
-
76049116316
-
Induction and concurrent taxanes enhance both the pulmonary metabolic radiation response and the radiation pneumonitis response in patients with esophagus cancer
-
McCurdy M, McAleer MF, Wei W, et al. Induction and concurrent taxanes enhance both the pulmonary metabolic radiation response and the radiation pneumonitis response in patients with esophagus cancer. Int J Radiat Oncol Biol Phys. 2010; 76: 816-823.
-
(2010)
Int J Radiat Oncol Biol Phys.
, vol.76
, pp. 816-823
-
-
McCurdy, M.1
McAleer, M.F.2
Wei, W.3
|